Stratview Research has published a new report on the Allergy Diagnostic and Treatment Market, segmented By Allergy Type (Inhaled Allergens, Food Allergens, Drug Allergens, Other Allergens) Diagnostic Tests (Specific IgE Testing, Patch Testing, Blood Testing, Others), Drug Class (Antihistamines, Decongestants, Corticosteroids, Leukotrienes Inhibitors, Mast Cell inhibitors, Others), End-User (Diagnostic Laboratories, Hospitals, Academic Research Institutes) and Region.
This market research report provides in-depth information on trends, dynamics, revenue opportunities, competitive landscape, and recent developments in the global artificial intelligence as a service market.
Market Highlights
The Allergy Diagnostic and Treatment Market is expected to grow from USD 33.1 billion in 2020 to USD 45.4 billion by 2026 at a CAGR of over 5.5% during the forecast period.
To know more about the covid impact on the market, click here: https://www.stratviewresearch.com/Request-Sample/2427/Allergy-Diagnostic-and-Treatment-Market.html#form
Covid Impact
Covid-19 has impacted the market dynamics, competition, and global supply chain of every possible market one can think of. The revenues for many, have gone down in 2020 and may resume an uptrend gradually from 2021. Companies optimizing their operations and strategy will sustain and beat the competition.
Segmentation –
This report studies the Allergy Diagnostic and Treatment Market and has segmented the market in a few ways, keeping in mind the concentration of all the stakeholders across the value chain. Following are the ways in which the market has been segmented in the report:
Based on end-users, the market has been segmented into diagnostic laboratories, hospitals, and academic research institutes. The hospitals' segment accounted for the largest market share in 2020 and is projected to register significant CAGR during the review period. The segment growth can be attributed to the presence of established healthcare infrastructure and skilled staff.
Geographically, the market in North America accounted for the largest market share in 2020 and is expected to register significant CAGR during the review period. The market growth can be attributed to the high demand for advanced allergy diagnostic solutions in the healthcare sector coupled with the presence of key market players such as Danaher Corporation (US) and Lincoln Diagnostics, LLC (US). The market in Asia-Pacific is expected to be driven by rising incidences of allergic diseases in developing countries, particularly China and India.
Following are the key players in the Allergy Diagnostic and Treatment Market:
· bioMérieux SA (France)
· Danaher Corporation (US)
· Siemens AG (Germany)
· Omega Diagnostics Group (UK)
· R-Biopharm AG (Germany)
· Lincoln Diagnostics, LLC (US)
· Thermo Fisher Scientific (US)
· HOB Biotech Group Corp., Ltd (China)
· Hycor Biomedical (US)
· Stallergenes Greer (UK).
About Stratview Research-
Stratview Research is a global market intelligence firm having a strong team of industry veterans and research analysts. Stratview Research has been serving multiple clients across a wide array of industries. Our services cover a broad spectrum of industries including but not limited to Energy Chemicals, Advanced Materials, Automotive, and Aerospace. At Stratview, we believe in building long term relations with our clients.
Connect with our team here–
https://www.stratviewresearch.com/contact
Or
Call us @: +1-313-307-4176
Allergy Diagnostic and treatment market
